Invisible Barriers to Clinical Trials: The Impact of Structural, Infrastructural, and Procedural Barriers to Opening Oncology Clinical Trials von DILTS, David M, SANDIER, Alan B

Volltext

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib von MILLER, Vincent A, RIELY, Gregory J, HERBST, Roy S, HELLER, Glenn, LADANYI, Marc, PAO, William, JOHNSON, David H, ZAKOWSKI, Maureen F, LI, Allan R, PATEL, Jyoti D, HEELAN, Robert T, KRIS, Mark G, SANDIER, Alan B, CARBONE, David P, TSAO, Anne

Volltext

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer von HEYMACH, John V, PAZ-ARES, Luis, BONOMI, Philip D, HERBST, Roy S, KREBS, Annetta D, VASSELLI, James, JOHNSON, Bruce E, DE BRAUD, Filippo, SEBASTIAN, Martin, STEWART, David J, EBERHARDT, Wilfried E. E, RANADE, Anantbhushan A, COHEN, Graham, TRIGO, Jose Manuel, SANDIER, Alan B

Volltext

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy von VANSTEENKISTE, Johan, LARA, Primo N, PECK, Ronald, EDELMAN, Mark, LE CHEVALIER, Thierry, BRETON, Jean-Luc, BONOMI, Philip, SANDIER, Alan B, SOCINSKI, Mark A, DELBALDO, Catherine, MCHENRY, Brent, LEBWOHL, David

Volltext

Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program von DILTS, David M, SANDIER, Alan B, CHENG, Steven K, CRITES, Joshua S, FERRANTI, Lori B, WU, Amy Y, FINNIGAN, Shanda, FRIEDMAN, Steven, MOONEY, Margaret, ABRAMS, Jeffrey

Volltext

Inhibition of angiogenesis in the treatment of non‐small cell lung cancer von Keedy, Vicki L., Sandler, Alan B.

Volltext

Processes to Activate Phase III Clinical Trials in a Cooperative Oncology Group: The Case of Cancer and Leukemia Group B von DILTS, David M, SANDIER, Alan B, SCOGGINS, Maren, WU, Amy, KAI ZHOU, SCHILSKY, Richard L, BAKER, Matthew, CHENG, Steven K, GEORGE, Stephen L, KARAS, Kathleen S, MCGUIRE, Stephen, MENON, Gourija S, REUSCH, Jason, SAWYER, Debbie

Volltext

E-66. Clinical experience with Tarceva von Sandier, Alan B.

Volltext

Targeting Angiogenesis in Lung Cancer von Sandler, Alan B.

Volltext

COX-2 inhibition and lung cancer: The role of COX-2 carcinogenesis von SANDIER, Alan B, DUBINETT, Steven M

Volltext

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors von KOBAYASHI, Hiroyuki, GAIL ECKHARDT, S, WOLIN, Maurice, BASCHE, Michele L, LOCKRIDGE, Jennifer A, ROTHENBERG, Mace L, SANDIER, Alan B, O'BRYANT, Cindy L, COOPER, Wendy, HOLDEN, Scott N, AITCHISON, Roger D, USMAN, Nassim

Volltext

Treatment of non-small cell lung cancer, Stage IV ACCP evidence-based clinical practice guidelines (2nd Edition): Diagnosis and management of lung cancer: ACCP evidence-based clini... von SOCINSKI, Mark A, CROWELL, Richard, HENSING, Thomas E, LANGER, Corey J, LILENBAUM, Rogerio, SANDIER, Alan B, MORRIS, David

Volltext

Redefining bronchioloalveolar carcinoma: Non-small cell lung cancer von LASKIN, Janessa J, SANDIER, Alan B, JOHNSON, David H

Volltext

Role of computed tomography in the staging of primary melanoma von BUZAID, A. C, SANDLER, A. B, SRIDHAR MANI, CURTIS, A. M, WEN-JEN POO, BOLOGNIA, J. L, ARIYAN, S

Volltext

Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies von HANNA, Nasser H, GORDON, Michael S, FIFE, Karen, SANDIER, Alan B

Volltext

A Phase I Pilot Study of BCNU plus Thymidine in Patients with Refractory Cancer von Schultz, Michelle Z., Sandier, Alan B., Durivage, Henry J., Cooper, Dennis L.

Volltext

Neuron-specific enolase as a tumor marker in metastatic melanoma von BUZAID, A. C, SANDLER, A. B, HAYDEN, C. L, SCINTO, J, WEN-JEN POO, CLARK, M. B, HOTCHKISS, S

Volltext

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer von HANNA, Nasser, BUNN, Paul A, HARIHARAN, Subramanian, WANG, Benjamin, SANDIER, Alan, LONGER, Corey, EINHORN, Lawrence, GUTHRIE, Troy, BECK, Thaddeus, ANSARI, Rafat, ELLIS, Peter, BYRNE, Michael, MORRISON, Mark

Volltext

Epidermal growth factor receptor: a promising target in solid tumours von Laskin, Janessa J., Sandler, Alan B.

Volltext

Presence of hydrosalpinx correlated to endometrial inflammatory response in vivo von Copperman, Alan B., Wells, Valerie, Luna, Martha, Kalir, Tamara, Sandler, Benjamin, Mukherjee, Tanmoy

Volltext